Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases
Abstract Background ChAdOx1 nCoV-19 (AstraZeneca) and Ad26COV2.S (Johnson & Johnson/Janssen) adenoviral vector vaccines have been associated with vaccine-induced immune thrombotic thrombocytopenia (VITT). Arterial thrombosis and acute limb ischemia have been described in a minority of patients w...
Main Authors: | Guillaume Roberge, Benoit Côté, Anthony Calabrino, Nathalie Gilbert, Nathalie Gagnon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-022-00398-8 |
Similar Items
-
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia
by: Bianca Clerici, et al.
Published: (2024-06-01) -
Long-term anti-PF4 persistence in autoimmune heparin-induced thrombocytopenia: A glimpse into the natural history of vaccine-induced immune thrombotic thrombocytopenia
by: Guillaume Roberge, et al.
Published: (2021-12-01) -
Acute limb ischemia secondary to vaccine-induced thrombotic thrombocytopenia
by: Bowen Xie, et al.
Published: (2023-03-01) -
COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review
by: Malay Sarkar, et al.
Published: (2022-01-01) -
Heparininduced thrombocytopenia in patients with venous thromboembolic complications – clinical cases and review of the literature
by: N. Yu. Semigolovskii, et al.
Published: (2018-04-01)